Centre for Chronic Disease, School of Medicine, University of Queensland, Herston, QLD 4029, Australia.
Diabetes Metab Res Rev. 2010 Feb;26(2):109-14. doi: 10.1002/dmrr.1060.
China has experienced a rapid increase in diabetes. In this study, we assessed whether the associations of two adipocyte-derived hormones, leptin and adiponectin, with type 2 diabetes are independent of obesity in older Chinese adults.
In this matched case-control study, each of the 619 diabetes and impaired fasting glucose (IFG) cases aged 60-96 years was matched to a control by age, sex, waist circumference and body mass index (BMI).
Before matching, IFG and diabetes cases had significantly lower adiponectin and higher leptin concentrations than the participants with normal glucose. After matching for age, sex, waist circumference and BMI, the differences between cases and controls remained significant (p < 0.001) in adiponectin but not in leptin (p = 0.77). Adjusted odds ratios for the combined outcome of diabetes and IFG were 1.03 (95% confidence interval: 0.88, 1.21; p = 0.71) for one standard deviation increase in plasma leptin and 0.79 (95% confidence interval: 0.69, 0.91; p < 0.001) for one standard deviation increase in plasma adiponectin.
Without adjustment for obesity related body size measurements of waist circumference and BMI, both adiponectin and leptin are associated with diabetes and IFG. After adjustment, adiponectin is independently associated with diabetes and IFG, but there is no independent association between leptin and either diabetes or IFG. Our findings suggest that adiponectin provides extra-predictive power beyond obesity while leptin does not independently predict the risk of diabetes and IFG in older Chinese adults.
中国的糖尿病发病率迅速上升。本研究旨在评估两种脂肪细胞衍生激素瘦素和脂联素与 2 型糖尿病的相关性是否独立于肥胖,研究对象为中国老年人群。
本病例对照研究共纳入 619 例年龄在 60-96 岁的 2 型糖尿病和空腹血糖受损(IFG)患者和 619 例对照。病例和对照按照年龄、性别、腰围和体重指数(BMI)进行 1:1 配对。
在匹配前,IFG 和糖尿病组的脂联素水平显著低于糖耐量正常组,而瘦素水平显著高于糖耐量正常组。在匹配年龄、性别、腰围和 BMI 后,脂联素在病例和对照组间的差异仍有统计学意义(p < 0.001),而瘦素无此差异(p = 0.77)。将糖尿病和 IFG 作为一个联合结局,瘦素每升高一个标准差,患病风险增加 1.03 倍(95%可信区间:0.88-1.21;p = 0.71);脂联素每升高一个标准差,患病风险降低 0.79 倍(95%可信区间:0.69-0.91;p < 0.001)。
不调整腰围和 BMI 等肥胖相关的人体测量指标时,瘦素和脂联素均与糖尿病和 IFG 相关。调整后,脂联素与糖尿病和 IFG 独立相关,而瘦素与糖尿病和 IFG 均无独立相关性。我们的研究结果提示,脂联素在肥胖之外提供了额外的预测价值,而瘦素不能独立预测中国老年人群糖尿病和 IFG 的发病风险。